Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Gedye

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Stem Cells (Dayton, Ohio)|November 22, 2011
Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profileMatthew Anaka, Claudia Freyer, Craig Gedye, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2011
Phenotypic heterogeneity and instability of human ovarian tumor-initiating cellsJocelyn M Stewart, Patricia A Shaw, Craig Gedye, et al.
Psycho-Oncology|July 15, 2025
How to Support Participants in Urogenital and Prostate Clinical Trials: A Qualitative PerspectiveNatasha A Roberts, Ian D Davis, David Wyld, et al.
Endocrine-Related Cancer|March 30, 2017
Targeting the TSH receptor in thyroid cancerChristopher W Rowe, Jonathan W Paul, Craig Gedye, et al.
Proteomics. Clinical Applications|February 25, 2018
Cell-Free DNA Blood Collection Tubes Are Appropriate for Clinical Proteomics: A Demonstration in Colorectal CancerJuhura G Almazi, Peter Pockney, Craig Gedye, et al.
FASEB Bioadvances|May 8, 2023
Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapyAmiee Dowdell, Mark Marsland, Sam Faulkner, et al.
Oncology Letters|February 20, 2016
Real-world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanomaLeila Khoja, Eshetu G Atenafu, Qian Ye, et al.
British Journal of Cancer|October 5, 2016
Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patientsLeila Khoja, Minnie Kibiro, Ur Metser, et al.
Cancers|May 13, 2023
The Membrane Protein Sortilin Is a Potential Biomarker and Target for GlioblastomaMark Marsland, Amiee Dowdell, Sam Faulkner, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2009
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cellsCraig Gedye, Juliet Quirk, Judy Browning, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Stem Cells (Dayton, Ohio)|November 22, 2011
Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profileMatthew Anaka, Claudia Freyer, Craig Gedye, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2011
Phenotypic heterogeneity and instability of human ovarian tumor-initiating cellsJocelyn M Stewart, Patricia A Shaw, Craig Gedye, et al.
Psycho-Oncology|July 15, 2025
How to Support Participants in Urogenital and Prostate Clinical Trials: A Qualitative PerspectiveNatasha A Roberts, Ian D Davis, David Wyld, et al.
Endocrine-Related Cancer|March 30, 2017
Targeting the TSH receptor in thyroid cancerChristopher W Rowe, Jonathan W Paul, Craig Gedye, et al.
Proteomics. Clinical Applications|February 25, 2018
Cell-Free DNA Blood Collection Tubes Are Appropriate for Clinical Proteomics: A Demonstration in Colorectal CancerJuhura G Almazi, Peter Pockney, Craig Gedye, et al.
FASEB Bioadvances|May 8, 2023
Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapyAmiee Dowdell, Mark Marsland, Sam Faulkner, et al.
Oncology Letters|February 20, 2016
Real-world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanomaLeila Khoja, Eshetu G Atenafu, Qian Ye, et al.
British Journal of Cancer|October 5, 2016
Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patientsLeila Khoja, Minnie Kibiro, Ur Metser, et al.
Cancers|May 13, 2023
The Membrane Protein Sortilin Is a Potential Biomarker and Target for GlioblastomaMark Marsland, Amiee Dowdell, Sam Faulkner, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2009
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cellsCraig Gedye, Juliet Quirk, Judy Browning, et al.
Pageof 8